Compounds are provided that act as potent antagonists of chemokine receptors. The compounds are generally aryl sulfonamide derivatives and are useful in pharmaceutical compositions, methods for the treatment of chemokine receptor-mediated diseases, and as controls in assays for the identification of chemokine antagonists.
提供了作为
趋化因子受体强效拮抗剂的化合物。这些化合物通常是芳基磺酰胺衍
生物,可用于制备制药组合物、治疗
趋化因子受体介导的疾病的方法,以及作为
化学试剂中
趋化因子拮抗剂的鉴定控制。